As BNP expression level is reported to be a most reliable marker of disease severity [23] in heart failure, and its basal expression level is quite low in normal hearts and practically negligible in other organs, BNP promoter activity may afford control over therapeutic gene expression in both a disease-severity-dependent- and heart-muscle-specific manner. The gene discussed is NPPB; the disease is heart failure.